VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 17 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,237,478 | -10.6% | 1,160,813 | 0.0% | 3.12% | -25.7% |
Q2 2023 | $34,952,079 | +81.3% | 1,160,813 | +94.8% | 4.20% | +75.3% |
Q1 2023 | $19,274,551 | +7.8% | 595,813 | -4.5% | 2.40% | +2.3% |
Q4 2022 | $17,886,505 | +18.8% | 624,093 | 0.0% | 2.34% | +34.0% |
Q3 2022 | $15,053,000 | -70.6% | 624,093 | -66.7% | 1.75% | -4.7% |
Q2 2022 | $51,261,000 | +114.2% | 1,872,279 | +200.0% | 1.84% | +11.0% |
Q1 2022 | $23,934,000 | +19.7% | 624,093 | 0.0% | 1.66% | +31.9% |
Q4 2021 | $19,990,000 | +58.1% | 624,093 | +45.4% | 1.26% | +73.6% |
Q3 2021 | $12,646,000 | -12.8% | 429,093 | +0.6% | 0.72% | -10.3% |
Q2 2021 | $14,500,000 | +85.1% | 426,717 | +113.4% | 0.81% | -22.2% |
Q3 2020 | $7,832,000 | -45.2% | 200,000 | -48.7% | 1.04% | +18.7% |
Q2 2020 | $14,286,000 | +327.6% | 389,500 | +168.6% | 0.87% | +254.9% |
Q1 2020 | $3,341,000 | -20.2% | 145,000 | +1.4% | 0.25% | +25.5% |
Q4 2019 | $4,187,000 | – | 143,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |